{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:28:12Z","timestamp":1779935292934,"version":"3.53.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005187","name":"University of Athens","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although congestion is present in the large majority of patients hospitalized with acute heart failure (AHF), the pharmacological options to treat it remain poorly studied, with heterogeneity in real-world practices and outcomes. The best available evidence supports that patients with AHF and congestion should be initially treated with i.v. loop diuretics with their dose tailored to early (within 2\u20136\u00a0h) diuretic response, as assessed by spot urine sodium and\/or hourly urine output. If diuretic response is sub-optimal, the next best steps seem to be increases in i.v. loop diuretics and addition of a thiazide and\/or i.v. acetazolamide. Irrespective of the above, sodium-glucose co-transporter-2 inhibitors and spironolactone should be started in all patients with AHF as early as possible. Changes in serum creatinine in this scenario do not typically represent true worsening in renal function and should, thus, not lead to de-escalation of decongestion therapy.<\/jats:p>","DOI":"10.1007\/s10741-025-10548-5","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T05:50:57Z","timestamp":1756533057000},"page":"1275-1290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacological options to relieve congestion in acute heart failure"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1616-6307","authenticated-orcid":false,"given":"Chris J.","family":"Kapelios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Vazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"10548_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2023.09.030","volume":"12","author":"A Lala","year":"2024","unstructured":"Lala A, Hamo CE, Bozkurt B, Fiuzat M, Blumer V, Bukhoff D, Butler J, Costanzo MR, Felker GM, Filippatos G, Konstam MA, McMurray JJV, Mentz RJ, Metra M, Psotka MA, Solomon SD, Teerlink J, Abraham WT, O\u2019Connor CM, HF-ARC (Heart Failure Collaboratory and Academic Research Consortium) (2024) Standardized definitions for evaluation of acute decompensated heart failure therapies. JACC: Heart Failure 12:1\u201315. https:\/\/doi.org\/10.1016\/j.jchf.2023.09.030","journal-title":"JACC: Heart Failure"},{"key":"10548_CR2","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/S2214-109X(20)30004-8","volume":"8","author":"J Tromp","year":"2020","unstructured":"Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W, Tay WT, Dickstein K, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Lam CSP, Filippatos G, Collins SP (2020) Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. Lancet Glob Health 8:e411\u2013e422. https:\/\/doi.org\/10.1016\/S2214-109X(20)30004-8","journal-title":"Lancet Glob Health"},{"key":"10548_CR3","doi-asserted-by":"publisher","unstructured":"Kapelios CJ, Shahim B, Lund LH, Savarese G (2023) Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction. Card Fail Rev 9:e14. https:\/\/doi.org\/10.15420\/cfr.2023.03.","DOI":"10.15420\/cfr.2023.03"},{"key":"10548_CR4","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ejhf.1492","volume":"21","author":"O Chioncel","year":"2019","unstructured":"Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C, Piepoli MF, Crespo-Leiro MG, Lainscak M, Ponikowski P, Filippatos G, Ruschitzka F, Seferovic P, Coats AJS, Lund LH, Heart Failure Long-Term Registry Investigators ESC-EORP-HFA (2019) Acute heart failure congestion and perfusion status \u2013 impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA heart failure long-term registry. Eur J Heart Fail 21:1338\u20131352. https:\/\/doi.org\/10.1002\/ejhf.1492","journal-title":"Eur J Heart Fail"},{"key":"10548_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jchf.2017.09.023","volume":"6","author":"Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J Jr, Sebbag L, Zannad F, Mebazaa A, Rossignol P; INI-CRCT, Great Network, and the EF-HF Group","year":"2018","unstructured":"Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J Jr, Sebbag L, Zannad F, Mebazaa A, Rossignol P; INI-CRCT, Great Network, and the EF-HF Group (2018) Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. JACC Heart Fail 6:273\u2013285. https:\/\/doi.org\/10.1016\/j.jchf.2017.09.023","journal-title":"JACC Heart Fail"},{"key":"10548_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jchf.2024.09.013","volume":"13","author":"M Pagnesi","year":"2025","unstructured":"Pagnesi M, Staal L, Ter Maaten JM, Beldhuis IE, Cotter G, Davison BA, Jongs N, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Lombardi CM, Adamo M, Severin T, Gimpelewicz C, Voors AA, Teerlink JR, Metra M (2025) Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial. JACC Heart Fail 13:414\u2013429. https:\/\/doi.org\/10.1016\/j.jchf.2024.09.013","journal-title":"JACC Heart Fail"},{"key":"10548_CR7","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/ejhf.2985","volume":"25","author":"A Vazir","year":"2023","unstructured":"Vazir A, Kapelios CJ, Agaoglu E, Metra M, Lopatin Y, Seferovic P, Mullens W, Filippatos G, Rosano G, Coats AJS, Chioncel O (2023) Decongestion strategies in patients presenting with acutely decompensated heart failure: a worldwide survey among physicians. Eur J Heart Fail 25:1555\u20131570. https:\/\/doi.org\/10.1002\/ejhf.2985","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10548_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ejhf.2708","volume":"25","author":"W Ouwerkerk","year":"2023","unstructured":"Ouwerkerk W, Tromp J, Cleland JGF, Angermann CE, Dahlstrom U, Ertl G et al (2023) Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. Eur J Heart Fail 25(1):43\u201351. https:\/\/doi.org\/10.1002\/ejhf.2708","journal-title":"Eur J Heart Fail"},{"key":"10548_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/ehjcvp\/pvx020","volume":"4","author":"CJ Kapelios","year":"2018","unstructured":"Kapelios CJ, Malliaras K, Kaldara E, Vakrou S, Nanas JN (2018) Loop diuretics for chronic heart failure: A foe in disguise of a friend? Eur Heart J Cardiovasc Pharmacother 4:54\u201363. https:\/\/doi.org\/10.1093\/ehjcvp\/pvx020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10548_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/ejhf.2874","volume":"25","author":"M Metra","year":"2023","unstructured":"Metra M, Adamo M, Tomasoni D, Bayes-Genis A, Filippatos G, Abdelhamid M, Adamopoulos S, Anker SD, Antohi L, B\u00f6hm M, Braunschweig F, Gal TB, Butler J, Cleland JGF, Cohen-Solal A, Damman K, Gustafsson F, Hill L, Jankowska EA, Lainscak M, Lund LH, McDonagh T, Mebazaa A, Moura B, Mullens W, Piepoli M, Ponikowski P, Rakisheva A, Ristic A, Savarese G, Seferovic P, Sharma R, Tocchetti CG, Yilmaz MB, Vitale C, Volterrani M, von Haehling S, Chioncel O, Coats AJS, Rosano G (2023) Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC. Eur J Heart Fail 25:1115\u20131131. https:\/\/doi.org\/10.1002\/ejhf.2874","journal-title":"Eur J Heart Fail"},{"key":"10548_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/j.1552-4604.1982.tb02644.x","volume":"22","author":"A Vermeulen","year":"1982","unstructured":"Vermeulen A, Chadha DR (1982) Slow-release furosemide and hydrochlorothiazide in congestive cardiac failure: a controlled trial. J Clin Pharmacol 22:513\u2013519. https:\/\/doi.org\/10.1002\/j.1552-4604.1982.tb02644.x","journal-title":"J Clin Pharmacol"},{"key":"10548_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 24:4\u2013131. https:\/\/doi.org\/10.1002\/ejhf.2333","journal-title":"Eur J Heart Fail"},{"key":"10548_CR13","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary. J Am Coll Cardiol 79:e263\u2013e421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"key":"10548_CR14","doi-asserted-by":"publisher","unstructured":"Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJS (2012) Diuretics for heart failure. Cochrane Database Syst Rev (2):CD003838. https:\/\/doi.org\/10.1002\/14651858.CD003838.pub4.","DOI":"10.1002\/14651858.CD003838.pub4"},{"key":"10548_CR15","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/ejhf.619","volume":"18","author":"CJ Kapelios","year":"2016","unstructured":"Kapelios CJ, Malliaras K, Nanas JN (2016) Dosing of loop diuretics in chronic heart failure: it\u2019s time for evidence. Eur J Heart Fail 18:1298. https:\/\/doi.org\/10.1002\/ejhf.619","journal-title":"Eur J Heart Fail"},{"key":"10548_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O'Connor CM; NHLBI Heart Failure Clinical Research Network","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O\u2019Connor CM; NHLBI Heart Failure Clinical Research Network (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419","journal-title":"N Engl J Med"},{"key":"10548_CR17","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.amjcard.2019.08.034","volume":"124","author":"M Griffin","year":"2019","unstructured":"Griffin M, Rao VS, Fleming J, Raghavendra P, Turner J, Mahoney D, Wettersten N, Maisel A, Ivey-Miranda JB, Inker L, Tang WHW, Wilson FP, Testani JM (2019) Effect on survival of concurrent hemoconcentration and increase in creatinine during treatment of acute decompensated heart failure. Am J Cardiol 124:1707\u20131711. https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.034","journal-title":"Am J Cardiol"},{"key":"10548_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005552","volume":"12","author":"VS Rao","year":"2019","unstructured":"Rao VS, Ahmad T, Brisco-Bacik MA, Bonventre JV, Wilson FP, Siew ED, Felker GM, Anstrom KK, Mahoney DD, Bart BA, Tang WHW, Velazquez EJ, Testani JM (2019) Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circ Heart Fail 12:e005552. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005552","journal-title":"Circ Heart Fail"},{"key":"10548_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.009776","volume":"16","author":"PS Natov","year":"2023","unstructured":"Natov PS, Ivey-Miranda JB, Cox ZL, Moreno-Villagomez J, Maulion C, Bellumkonda L, Shlipak MG, Estrella MM, Borlaug BA, Rao VS, Testani JM (2023) Improvement in renal function during the treatment of acute decompensated heart failure: relationship with markers of renal tubular injury and prognostic importance. Circ Heart Fail 16:e009776. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.009776","journal-title":"Circ Heart Fail"},{"key":"10548_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","volume":"5","author":"M Metra","year":"2012","unstructured":"Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L (2012) Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure? Circ Heart Fail 5:54\u201362. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.111.963413","journal-title":"Circ Heart Fail"},{"key":"10548_CR21","doi-asserted-by":"publisher","unstructured":"Filippatos G, Farmakis D, Parissis J (2014) Renal dysfunction and heart failure: things are seldom what they seem. Eur Heart J 35:416\u2013418. https:\/\/doi.org\/10.1093\/eurheartj\/eht515","DOI":"10.1093\/eurheartj\/eht515"},{"key":"10548_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jacc.2024.11.041","volume":"85","author":"A Lala","year":"2025","unstructured":"Lala A, Coca S, Feinman J, Hamo CE, Fiuzat M, Abraham WT, O\u2019Connor C, Lindenfeld J, Januzzi J, Cavagna I, Teerlink JR, Sarnak MJ, Parikh CR, McCallum W, Konstam MA, Costanzo MR (2025) Standardized definitions of changes in kidney function in trials of heart failure. J Am Coll Cardiol 85:766\u2013781. https:\/\/doi.org\/10.1016\/j.jacc.2024.11.041","journal-title":"J Am Coll Cardiol"},{"key":"10548_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","volume":"7","author":"JM Testani","year":"2014","unstructured":"Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR, Tang WH (2014) Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7:261\u2013270. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000895","journal-title":"Circ Heart Fail"},{"key":"10548_CR24","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1038\/s41591-023-02532-z","volume":"29","author":"JM Ter Maaten","year":"2023","unstructured":"Ter Maaten JM, Beldhuis IE, van der Meer P, Krikken JA, Postmus D, Coster JE, Nieuwland W, van Veldhuisen DJ, Voors AA, Damman K (2023) Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial. Nat Med 29:2625\u20132632. https:\/\/doi.org\/10.1038\/s41591-023-02532-z","journal-title":"Nat Med"},{"key":"10548_CR25","doi-asserted-by":"publisher","unstructured":"Lund LH, Crespo-Leiro MG, Laroche C, Zaliaduonyte D, Saad AM, Fonseca C, \u010celutkien\u0117 J, Zdravkovic M, Bielecka-Dabrowa AM, Agostoni P, Xuereb RG, Neronova KV, Lelonek M, Cavusoglu Y, Gellen B, Abdelhamid M, Hammoudi N, Anker SD, Chioncel O, Filippatos G, Lainscak M, McDonagh TA, Mebazaa A, Piepoli M, Ruschitzka F, Seferovi\u0107 PM, Savarese G, Metra M, Rosano GMC, Maggioni AP; ESC EORP HF III National Leaders and Investigators (2024) Heart failure in Europe: Guideline\u2010directed medical therapy use and decision making in chronic and acute, pre\u2010existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction \u2013 the ESC EORP Heart Failure III Registry. Eur J Heart Fail 26:2487\u20132501. https:\/\/doi.org\/10.1002\/ejhf.3445.","DOI":"10.1002\/ejhf.3445"},{"key":"10548_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, Testani JM, Tang WHW, Orso F, Rossignol P, Metra M, Filippatos G, Seferovic PM, Ruschitzka F, Coats AJ (2019) The use of diuretics in heart failure with congestion \u2014 a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21:137\u2013155. https:\/\/doi.org\/10.1002\/ejhf.1369","journal-title":"Eur J Heart Fail"},{"key":"10548_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ahj.2024.12.010","volume":"282","author":"G Bullock","year":"2025","unstructured":"Bullock G, Jacobs JA, Carey JR, Pan IZ, Kinsey MS, Sideris K, Kapelios CJ, Stehlik J, Fang JC, Das S, Carter SJ (2025) Patterns of diuretic titration during inpatient management of acute decompensated heart failure. Am Heart J 282:30\u201339. https:\/\/doi.org\/10.1016\/j.ahj.2024.12.010","journal-title":"Am Heart J"},{"key":"10548_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1001\/jama.2022.23924","volume":"329","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S, Testani JM, Harrington AH, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Velazquez EJ, Investigators TRANSFORM-HF (2023) Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA 329:214\u2013223. https:\/\/doi.org\/10.1001\/jama.2022.23924","journal-title":"JAMA"},{"key":"10548_CR29","doi-asserted-by":"publisher","unstructured":"Jacobs JA, Carter SJ, Bullock G, Carey JR, Pan IZ, Kinsey MS, Zheutlin AR, Kapelios CJ, Raju S, Fang JC, Shah KS, Bress AP (2024) Optimal Initial Intravenous Loop Diuretic Dosing in Acute Decompensated Heart Failure. JACC: Advances 3:101250. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101250.","DOI":"10.1016\/j.jacadv.2024.101250"},{"key":"10548_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1681\/ASN.0000000000000481","volume":"36","author":"VS Rao","year":"2025","unstructured":"Rao VS, Cox ZL, Ivey-Miranda JB, Neville D, Balkcom N, Moreno-Villagomez J, Ramos-Mastache D, Maulion C, Bellumkonda L, Tang WHW, Collins SP, Velazquez EJ, Mentz RJ, Wilson FP, Turner JM, Wilcox CS, Ellison DH, Fang JC, Testani JM (2025) Mechanistic differences between torsemide and furosemide. J Am Soc Nephrol 36:99\u2013107. https:\/\/doi.org\/10.1681\/ASN.0000000000000481","journal-title":"J Am Soc Nephrol"},{"key":"10548_CR31","doi-asserted-by":"publisher","unstructured":"Trull\u00e0s JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, S\u00e1nchez-Marteles M, Conde-Martel A, D\u00e1vila-Ramos MF, Ll\u00e1cer P, Salamanca-Bautista P, P\u00e9rez-Silvestre J, Plas\u00edn M\u00c1, Cerqueiro JM, Gil P, Formiga F, Manzano L; CLOROTIC trial investigators (2023) Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J 44:411\u2013421. https:\/\/doi.org\/10.1093\/eurheartj\/ehac689.","DOI":"10.1093\/eurheartj\/ehac689"},{"key":"10548_CR32","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jchf.2024.04.014","volume":"12","author":"AR Abbo","year":"2024","unstructured":"Abbo AR, Gruber A, Volis I, Aronson D, Girerd N, Lund Kristensen S, Zukermann R, Alberkant N, Sitnitsky E, Kruger A, Khasis P, Bravo E, Elad B, Helmer Levin L, Caspi O (2024) Diuresis Efficacy in Ambulatory Congested Heart Failure Patients. JACC Heart Fail 12:1396\u20131405. https:\/\/doi.org\/10.1016\/j.jchf.2024.04.014","journal-title":"JACC Heart Fail"},{"key":"10548_CR33","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.cardfail.2022.05.011","volume":"28","author":"T Cisowska","year":"2022","unstructured":"Cisowska T, Pan IZ, Biskupiak J, Shah KS, Fang JC, Jacobs JA (2022) Metolazone versus intravenous chlorothiazide for decompensated heart failure sequential nephron blockade: a retrospective cohort study. J Card Fail 28:1367\u20131371. https:\/\/doi.org\/10.1016\/j.cardfail.2022.05.011","journal-title":"J Card Fail"},{"key":"10548_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jchf.2019.09.012","volume":"8","author":"ZL Cox","year":"2020","unstructured":"Cox ZL, Hung R, Lenihan DJ, Testani JM (2020) Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial. JACC Heart Fail 8:157\u2013168. https:\/\/doi.org\/10.1016\/j.jchf.2019.09.012","journal-title":"JACC Heart Fail"},{"key":"10548_CR35","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.3390\/jcm10184207","volume":"10","author":"A Palazzuoli","year":"2021","unstructured":"Palazzuoli A, Ruocco G, Severino P, Gennari L, Pirrotta F, Stefanini A, Tramonte F, Feola M, Mancone M, Fedele F (2021) Effects of metolazone administration on congestion, diuretic response and renal function in patients with advanced heart failure. J Clin Med 10:4207. https:\/\/doi.org\/10.3390\/jcm10184207","journal-title":"J Clin Med"},{"key":"10548_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009149","volume":"7","author":"MA Brisco-Bacik","year":"2018","unstructured":"Brisco-Bacik MA, Ter Maaten JM, Houser SR, Vedage NA, Rao V, Ahmad T, Wilson FP, Testani JM (2018) Outcomes associated with a strategy of adjuvant metolazone or high-dose loop diuretics in acute decompensated heart failure: A propensity analysis. J Am Heart Assoc 7:e009149. https:\/\/doi.org\/10.1161\/JAHA.118.009149","journal-title":"J Am Heart Assoc"},{"key":"10548_CR37","doi-asserted-by":"publisher","unstructured":"Channer KS, McLean KA, Lawson-Matthew P, Richardson M (1994) Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J 71:146\u2013150. https:\/\/doi.org\/10.1136\/hrt.71.2.146","DOI":"10.1136\/hrt.71.2.146"},{"key":"10548_CR38","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1136\/hrt.71.2.146","volume":"56","author":"JC Jentzer","year":"2010","unstructured":"Jentzer JC, DeWald TA, Hernandez AF (2010) Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure. J Am Coll Cardiol 56:1527\u20131534. https:\/\/doi.org\/10.1136\/hrt.71.2.146","journal-title":"J Am Coll Cardiol"},{"key":"10548_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11886-020-01384-0","volume":"22","author":"WHW Tang","year":"2020","unstructured":"Tang WHW, Kiang A (2020) Acute Cardiorenal Syndrome in Heart Failure: from Dogmas to Advances. Curr Cardiol Rep 22:143. https:\/\/doi.org\/10.1007\/s11886-020-01384-0","journal-title":"Curr Cardiol Rep"},{"key":"10548_CR40","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ejhf.1478","volume":"21","author":"FH Verbrugge","year":"2019","unstructured":"Verbrugge FH, Martens P, Ameloot K, Haemels V, Penders J, Dupont M, Tang WHW, Droogn\u00e9 W, Mullens W (2019) Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail 21:1415\u20131422. https:\/\/doi.org\/10.1002\/ejhf.1478","journal-title":"Eur J Heart Fail"},{"key":"10548_CR41","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, Tartaglia K, Chenot F, Moubayed S, Dierckx R, Blouard P, Troisfontaines P, Derthoo D, Smolders W, Bruckers L, Droogne W, Ter Maaten JM, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M; ADVOR Study Group","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, Tartaglia K, Chenot F, Moubayed S, Dierckx R, Blouard P, Troisfontaines P, Derthoo D, Smolders W, Bruckers L, Droogne W, Ter Maaten JM, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M; ADVOR Study Group (2022) Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 387:1185\u20131195. https:\/\/doi.org\/10.1056\/NEJMoa2203094","journal-title":"N Engl J Med"},{"key":"10548_CR42","unstructured":"Kapelios CJ, Drakos SG, Fang JC (2022) Acetazolamide For Decongestion in Acute Heart Failure: An Old Relationship Revisited? American College of Cardiology. https:\/\/www.acc.org\/Latest-in-Cardiology\/Articles\/2022\/12\/15\/14\/37\/Acetazolamide-For-Decongestion-in-Acute-Heart-Failure . Accessed 3 July 2025"},{"key":"10548_CR43","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMe2209997","volume":"387","author":"GM Felker","year":"2022","unstructured":"Felker GM (2022) New decongestion strategies in an evolving heart failure landscape. N Engl J Med 387:1231\u20131233. https:\/\/doi.org\/10.1056\/NEJMe2209997","journal-title":"N Engl J Med"},{"key":"10548_CR44","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehad236","volume":"44","author":"P Martens","year":"2023","unstructured":"Martens P, Verbrugge FH, Dauw J, Nijst P, Meekers E, Augusto SN, Ter Maaten JM, Heylen L, Damman K, Mebazaa A, Filippatos G, Ruschitzka F, Tang WHW, Dupont M, Mullens W (2023) Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR trial. Eur Heart J 44:1995\u20132005. https:\/\/doi.org\/10.1093\/eurheartj\/ehad236","journal-title":"Eur Heart J"},{"key":"10548_CR45","doi-asserted-by":"publisher","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK; ESC Scientific Document Group (2023) 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 44:3627\u20133639. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195","DOI":"10.1093\/eurheartj\/ehad195"},{"key":"10548_CR46","doi-asserted-by":"publisher","unstructured":"Eng M, Bansal S (2014) Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure. Int J Cardiol 170:e68-e69. https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.023.","DOI":"10.1016\/j.ijcard.2013.11.023"},{"key":"10548_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","volume":"25","author":"JP Ferreira","year":"2014","unstructured":"Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H (2014) Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure. Eur J Intern Med 25:67\u201372. https:\/\/doi.org\/10.1016\/j.ejim.2013.08.711","journal-title":"Eur J Intern Med"},{"key":"10548_CR48","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","volume":"2","author":"Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM, Tang WHW, Whellan DJ, Shah M, Desvigne-Nickens P, Hernandez AF, Braunwald E; National Heart Lung and Blood Institute Heart Failure Clinical Research Network","year":"2017","unstructured":"Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM, Tang WHW, Whellan DJ, Shah M, Desvigne-Nickens P, Hernandez AF, Braunwald E; National Heart Lung and Blood Institute Heart Failure Clinical Research Network (2017) Efficacy and Safety of Spironolactone in Acute Heart Failure. JAMA Cardiol 2:950\u2013958. https:\/\/doi.org\/10.1001\/jamacardio.2017.2198","journal-title":"JAMA Cardiol"},{"key":"10548_CR49","doi-asserted-by":"publisher","unstructured":"Natov PS, Ivey-Miranda JB, Cox ZL, Rao VS, Butler J, Konstam MA, Kiernan MS, Kapur NK, Testani JM (2024) Increased Spironolactone Dosing in Acute Heart Failure Alters Potassium Homeostasis but Does not Enhance Decongestion. J Card Fail 30:1522\u20131526. https:\/\/doi.org\/10.1016\/j.cardfail.2024.06.008.","DOI":"10.1016\/j.cardfail.2024.06.008"},{"key":"10548_CR50","doi-asserted-by":"publisher","unstructured":"Kapelios CJ, Bonou M, Vogiatzi P, Tzanis G, Mantzouratou P, Lund LH, Barbetseas J. Association Between High-Dose Spironolactone and Decongestion in Patients with Acute Heart Failure: An Observational Retrospective Study. Am J Cardiovasc Drugs 18:415\u2013422. https:\/\/doi.org\/10.1007\/s40256-018-0290-3.","DOI":"10.1007\/s40256-018-0290-3"},{"key":"10548_CR51","doi-asserted-by":"publisher","first-page":"443","DOI":"10.7326\/M18-3285","volume":"171","author":"S Bansal","year":"2019","unstructured":"Bansal S, Munoz K, Brune S, Bailey S, Prasad A, Velagapudi C (2019) High-dose spironolactone when patients with acute decompensated heart failure are resistant to loop diuretics: a pilot study. Ann Intern Med 171:443\u2013447. https:\/\/doi.org\/10.7326\/M18-3285","journal-title":"Ann Intern Med"},{"issue":"1","key":"10548_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","volume":"44","author":"J Biegus","year":"2023","unstructured":"Biegus J, Voors AA, Collins SP, Kosiborod MN, Teerlink JR, Angermann CE, Tromp J, Ferreira JP, Nassif ME, Psotka MA, Brueckmann M, Salsali A, Blatchford JP, Ponikowski P (2023) Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J 44(1):41\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehac530","journal-title":"Eur Heart J"},{"key":"10548_CR53","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jacc.2024.02.009","volume":"83","author":"ZL Cox","year":"2024","unstructured":"Cox ZL, Collins SP, Hernandez GA, McRae AT 3rd, Davidson BT, Adams K, Aaron M, Cunningham L, Jenkins CA, Lindsell CJ, Harrell FE Jr, Kampe C, Miller KF, Stubblefield WB, Lindenfeld J (2024) Efficacy and safety of dapagliflozin in patients with acute heart failure. J Am Coll Cardiol 83:1295\u20131306. https:\/\/doi.org\/10.1016\/j.jacc.2024.02.009","journal-title":"J Am Coll Cardiol"},{"key":"10548_CR54","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","volume":"44","author":"SE Yeoh","year":"2023","unstructured":"Yeoh SE, Osmanska J, Petrie MC, Brooksbank KJM, Clark AL, Docherty KF, Foley PWX, Guha K, Halliday CA, Jhund PS, Kalra PR, McKinley G, Lang NN, Lee MMY, McConnachie A, McDermott JJ, Platz E, Sartipy P, Seed A, Stanley B, Weir RAP, Welsh P, McMurray JJV, Campbell RT (2023) Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. Eur Heart J 44:2966\u20132977. https:\/\/doi.org\/10.1093\/eurheartj\/ehad341","journal-title":"Eur Heart J"},{"key":"10548_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semnephrol.2011.09.006","volume":"31","author":"A Tuttolomondo","year":"2011","unstructured":"Tuttolomondo A, Pinto A, Parrinello G, Licata G (2011) Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites. Semin Nephrol 31:513\u2013522. https:\/\/doi.org\/10.1016\/j.semnephrol.2011.09.006","journal-title":"Semin Nephrol"},{"key":"10548_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijcard.2014.03.020","volume":"173","author":"S Gandhi","year":"2014","unstructured":"Gandhi S, Mosleh W, Myers RBH (2014) Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. Int J Cardiol 173:139\u2013145. https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.020","journal-title":"Int J Cardiol"},{"key":"10548_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jchf.2019.10.012","volume":"8","author":"M Griffin","year":"2020","unstructured":"Griffin M, Soufer A, Goljo E, Colna M, Rao VS, Jeon S, Raghavendra P, D\u2019Ambrosi J, Riello R, Coca SG, Mahoney D, Jacoby D, Ahmad T, Chen M, Tang WHW, Turner J, Mullens W, Wilson FP, Testani JM (2020) Real world use of hypertonic saline in refractory acute decompensated heart failure. JACC: Heart Failure 8:199\u2013208. https:\/\/doi.org\/10.1016\/j.jchf.2019.10.012","journal-title":"JACC: Heart Failure"},{"key":"10548_CR58","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/ejhf.3390","volume":"26","author":"M Cobo Marcos","year":"2024","unstructured":"Cobo Marcos M, de la Espriella R, Com\u00edn-Colet J, Zegr\u00ed-Reiriz I, Rubio Gracia J, Morales-Rull JL, Ll\u00e0cer P, D\u00edez-Villanueva P, Jim\u00e9nez-Marrero S, de Juan BJ, Ortiz Cort\u00e9s C, Restrepo-C\u00f3rdoba MA, Goirigolzarri-Artaza J, Garc\u00eda-Pinilla JM, Barrios E, Del Prado DS, Montero Hern\u00e1ndez E, Sanchez-Marteles M, N\u00fa\u00f1ez J (2024) Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial. Eur J Heart Fail 26:2118\u20132128. https:\/\/doi.org\/10.1002\/ejhf.3390","journal-title":"Eur J Heart Fail"},{"key":"10548_CR59","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.cardfail.2023.03.018","volume":"29","author":"RA Montgomery","year":"2023","unstructured":"Montgomery RA, Mauch J, Sankar P, Martyn T, Engelman T, Martens P, Faulkenberg K, Menon V, Estep JD, Tang WHW (2023) Oral sodium to preserve renal efficiency in acute heart failure: a randomized, placebo-controlled, double-blind study. J Card Fail 29:986\u2013996. https:\/\/doi.org\/10.1016\/j.cardfail.2023.03.018","journal-title":"J Card Fail"},{"key":"10548_CR60","doi-asserted-by":"publisher","unstructured":"Biegus J, Iwanek G, Testani J, Zymli\u0144ski R, Fudim M, Guzik M, Gajewski P, Ponikowski P (2025) Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-AHF): A prospective, randomized, mechanistic study. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.3708","DOI":"10.1002\/ejhf.3708"},{"key":"10548_CR61","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297:1319\u20131331. https:\/\/doi.org\/10.1001\/jama.297.12.1319","journal-title":"JAMA"},{"key":"10548_CR62","doi-asserted-by":"publisher","unstructured":"Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators (2007) Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials JAMA 297:1332\u20131343. https:\/\/doi.org\/10.1001\/jama.297.12.1332.","DOI":"10.1001\/jama.297.12.1332"},{"key":"10548_CR63","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","volume":"69","author":"GM Felker","year":"2017","unstructured":"Felker GM, Mentz RJ, Cole RT, Adams KF, Egnaczyk GF, Fiuzat M, Patel CB, Echols M, Khouri MG, Tauras JM, Gupta D, Monds P, Roberts R, O\u2019Connor CM (2017) Efficacy and safety of Tolvaptan in patients hospitalized with acute heart failure. J Am Coll Cardiol 69:1399\u20131406. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.004","journal-title":"J Am Coll Cardiol"},{"key":"10548_CR64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jchf.2024.09.017","volume":"13","author":"TJ Siddiqi","year":"2025","unstructured":"Siddiqi TJ, Packer M, Ezekowitz JA, Fonarow GC, Greene SJ, Kittleson M, Khan MS, Mentz RJ, Testani J, Voors AA, Butler J (2025) Diuretic potentiation strategies in acute heart failure. JACC: Heart Failure 13:14\u201327. https:\/\/doi.org\/10.1016\/j.jchf.2024.09.017","journal-title":"JACC: Heart Failure"},{"key":"10548_CR65","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/ejhf.3336","volume":"26","author":"G Voordes","year":"2024","unstructured":"Voordes G, Davison B, Biegus J, Edwards C, Damman K, Ter Maaten J, Mebazaa A, Takagi K, Adamo M, Ambrosy AP, Arrigo M, Barros M, Celutkiene J, \u010cerlinskait\u0117-Bajor\u0117 K, Chioncel O, Cohen-Solal A, Damasceno A, Deniau B, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pagnesi M, Pang P, Ponikowski P, Saidu H, Sliwa K, Tomasoni D, Cotter G, Voors AA (2024) Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF. Eur J Heart Fail 26:1480\u20131492. https:\/\/doi.org\/10.1002\/ejhf.3336","journal-title":"Eur J Heart Fail"},{"key":"10548_CR66","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/ejhf.2664","volume":"24","author":"J N\u00fa\u00f1ez","year":"2022","unstructured":"N\u00fa\u00f1ez J, de la Espriella R, Rossignol P, Voors AA, Mullens W, Metra M, Chioncel O, Januzzi JL, Mueller C, Richards AM, de Boer RA, Thum T, Arfsten H, Gonz\u00e1lez A, Abdelhamid M, Adamopoulos S, Anker SD, Gal TB, Biegus J, Cohen-Solal A, B\u00f6hm M, Emdin M, Jankowska EA, Gustafsson F, Hill L, Jaarsma T, Jhund PS, Lopatin Y, Lund LH, Milicic D, Moura B, Piepoli MF, Ponikowski P, Rakisheva A, Ristic A, Savarese G, Tocchetti CG, Van Linthout S, Volterrani M, Seferovic P, Rosano G, Coats AJS, Bayes-Genis A (2022) Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology. Eur J Heart Fail 24:1751\u20131766. https:\/\/doi.org\/10.1002\/ejhf.2664","journal-title":"Eur J Heart Fail"},{"key":"10548_CR67","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jchf.2019.01.007","volume":"7","author":"DZ Hodson","year":"2019","unstructured":"Hodson DZ, Griffin M, Mahoney D, Raghavendra P, Ahmad T, Turner J, Wilson FP, Tang WHW, Rao VS, Collins SP, Mullens W, Testani JM (2019) Natriuretic response is highly variable and associated with 6-month survival: insights from the ROSE-AHF trial. JACC Heart Fail 7:383\u2013391. https:\/\/doi.org\/10.1016\/j.jchf.2019.01.007","journal-title":"JACC Heart Fail"},{"key":"10548_CR68","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/ejhf.1753","volume":"22","author":"K Damman","year":"2020","unstructured":"Damman K, Ter Maaten JM, Coster JE, Krikken JA, van Deursen VM, Krijnen HK, Hofman M, Nieuwland W, van Veldhuisen DJ, Voors AA, van der Meer P (2020) Clinical importance of urinary sodium excretion in acute heart failure. Eur J Heart Fail 22:1438\u20131447. https:\/\/doi.org\/10.1002\/ejhf.1753","journal-title":"Eur J Heart Fail"},{"key":"10548_CR69","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.011105","volume":"17","author":"J Dauw","year":"2024","unstructured":"Dauw J, Charaya K, Lelonek M, Zegri-Reiriz I, Nasr S, Paredes-Paucar CP, Borb\u00e9ly A, Erdal F, Benkouar R, Cobo-Marcos M, Barge-Caballero G, George V, Zara C, Ross NT, Barker D, Lekhakul A, Frea S, Ghazi AM, Knappe D, Doghmi N, Klincheva M, Fialho I, Bovolo V, Findeisen H, Alhaddad IA, Galluzzo A, de la Espriella R, Tabbalat R, Mir\u00f3 \u00d2, Singh JS, Nijst P, Dupont M, Martens P, Mullens W (2024) Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study. Circ Heart Fail 17:e011105. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.123.011105","journal-title":"Circ Heart Fail"},{"key":"10548_CR70","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/ejhf.3429","volume":"26","author":"E Meekers","year":"2024","unstructured":"Meekers E, Martens P, Dauw J, Gruwez H, Dhont S, Nijst P, Verbrugge FH, Ameloot K, Verhaert D, Dupont M, Stassen J, Opdenacker M, Janssens S, Mullens W (2024) Nurse-led diuretic titration via a point-of-care urinary sodium sensor in patients with acute decompensated heart failure (EASY-HF): a single-centre, randomized, open-label study. Eur J Heart Fail 26:2129\u20132139. https:\/\/doi.org\/10.1002\/ejhf.3429","journal-title":"Eur J Heart Fail"},{"key":"10548_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2023.101059","volume":"2","author":"G Georges","year":"2023","unstructured":"Georges G, Fudim M, Burkhoff D, Leon MB, G\u00e9n\u00e9reux P (2023) Patient selection and end point definitions for decongestion studies in acute decompensated heart failure: part 2. J Soc Cardiovasc Angiogr Interv 2:101059. https:\/\/doi.org\/10.1016\/j.jscai.2023.101059","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10548_CR72","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jchf.2022.12.001","volume":"11","author":"B Bozkurt","year":"2023","unstructured":"Bozkurt B (2023) Successful decongestion as a clinical target, performance indicator, and as a study endpoint in hospitalized heart failure patients. JACC: Heart Failure 11:126\u2013129. https:\/\/doi.org\/10.1016\/j.jchf.2022.12.001","journal-title":"JACC: Heart Failure"},{"key":"10548_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000535641","volume":"14","author":"JP Islas-Rodr\u00edguez","year":"2024","unstructured":"Islas-Rodr\u00edguez JP, Miranda-Aquino T, Romero-Gonz\u00e1lez G, Hern\u00e1ndez-Del Rio J, Camacho-Guerrero JR, Covarrubias-Villa S, Ivey-Miranda JB, Ch\u00e1vez-\u00cd\u00f1iguez JS (2024) Effect on kidney function recovery guiding decongestion with VExUS in patients with cardiorenal syndrome 1: a randomized control trial. Cardiorenal Med 14:1\u201311. https:\/\/doi.org\/10.1159\/000535641","journal-title":"Cardiorenal Med"},{"key":"10548_CR74","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/ckj\/sfad031","volume":"16","author":"LF Kenneally","year":"2023","unstructured":"Kenneally LF, Lorenzo M, Romero-Gonz\u00e1lez G, Cobo M, N\u00fa\u00f1ez G, G\u00f3rriz JL, Barrios AG, Fudim M, de la Espriella R, N\u00fa\u00f1ez J (2023) Kidney function changes in acute heart failure: a practical approach to interpretation and management. Clin Kidney J 16:1587\u20131599. https:\/\/doi.org\/10.1093\/ckj\/sfad031","journal-title":"Clin Kidney J"},{"key":"10548_CR75","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","volume":"137","author":"T Ahmad","year":"2018","unstructured":"Ahmad T, Jackson K, Rao VS, Tang WHW, Brisco-Bacik MA, Chen HH, Felker GM, Hernandez AF, O\u2019Connor CM, Sabbisetti VS, Bonventre JV, Wilson FP, Coca SG, Testani JM (2018) Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury. Circulation 137:2016\u20132028. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030112","journal-title":"Circulation"},{"key":"10548_CR76","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ejhf.2384","volume":"24","author":"JE Emmens","year":"2022","unstructured":"Emmens JE, Ter Maaten JM, Matsue Y, Figarska SM, Sama IE, Cotter G, Cleland JGF, Davison BA, Felker GM, Givertz MM, Greenberg B, Pang PS, Severin T, Gimpelewicz C, Metra M, Voors AA, Teerlink JR (2022) Worsening renal function in acute heart failure in the context of diuretic response. Eur J Heart Fail 24:365\u2013374. https:\/\/doi.org\/10.1002\/ejhf.2384","journal-title":"Eur J Heart Fail"},{"key":"10548_CR77","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.amjcard.2015.01.019","volume":"115","author":"M Wattad","year":"2015","unstructured":"Wattad M, Darawsha W, Solomonica A, Hijazi M, Kaplan M, Makhoul BF, Abassi ZA, Azzam ZS, Aronson D (2015) Interaction between worsening renal function and persistent congestion in acute decompensated heart failure. Am J Cardiol 115:932\u2013937. https:\/\/doi.org\/10.1016\/j.amjcard.2015.01.019","journal-title":"Am J Cardiol"},{"key":"10548_CR78","doi-asserted-by":"publisher","unstructured":"Riccardi M, Pagnesi M, Lombardi CM, Metra M (2025) Severe Acute Kidney Injury in the Intensive Care Unit: step-to-step management (2025) Eur Heart J Acute Cardiovasc Care https:\/\/doi.org\/10.1093\/ehjacc\/zuaf084.","DOI":"10.1093\/ehjacc\/zuaf084"},{"key":"10548_CR79","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jacc.2024.04.055","volume":"84","author":"J Biegus","year":"2024","unstructured":"Biegus J, Mebazaa A, Davison B, Cotter G, Edwards C, \u010celutkien\u0117 J, Chioncel O, Cohen-Solal A, Filippatos G, Novosadova M, Sliwa K, Adamo M, Arrigo M, Lam CSP, Ter Maaten JM, Deniau B, Barros M, \u010cerlinskait\u0117-Bajor\u0117 K, Damasceno A, Diaz R, Gayat E, Kimmoun A, Pang PS, Pagnesi M, Saidu H, Takagi K, Tomasoni D, Voors AA, Metra M, Ponikowski P (2024) Effects of rapid uptitration of neurohormonal blockade on effective, sustainable decongestion and outcomes in STRONG-HF. J Am Coll Cardiol 84:323\u2013336. https:\/\/doi.org\/10.1016\/j.jacc.2024.04.055","journal-title":"J Am Coll Cardiol"},{"key":"10548_CR80","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cardfail.2024.09.002","volume":"31","author":"J Biegus","year":"2025","unstructured":"Biegus J, Cotter G, Davison BA, Freund Y, Voors AA, Edwards C, Novosadova M, Takagi K, Hayrapetyan H, Mshetsyan A, Mayranush D, Cohen-Solal A, Ter Maaten JM, Filippatos G, Chioncel O, Sadoune M, Pagnesi M, Simon T, Metra M, Mann DL, Mebazaa A, Ponikowski P (2025) The Effects of Burst Steroid Therapy on Short-term Decongestion in Acute Heart Failure Patients With Pro-inflammatory Activation: A Post Hoc Analysis of the CORTAHF Randomized, Open-label, Pilot Trial. J Card Fail 31:354\u2013366. https:\/\/doi.org\/10.1016\/j.cardfail.2024.09.002","journal-title":"J Card Fail"},{"key":"10548_CR81","doi-asserted-by":"publisher","unstructured":"Vanhentenrijk S, Verbeeck J, Kalpakos T, Vandoren V, Braeckeveldt L, L'hoyes W, Choustoulakis E, Roosens B, Tang WHW, Verwerft J, Verbrugge FH (2025) Rationale and Design of the DECONGEST (Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment) Study. J Card Fail 31:651\u2013660. https:\/\/doi.org\/10.1016\/j.cardfail.2024.08.044.","DOI":"10.1016\/j.cardfail.2024.08.044"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10548-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T20:04:44Z","timestamp":1763150684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10548-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":81,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10548"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10548-5","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]},"assertion":[{"value":"24 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CJK reports honoraria for lectures from Abbott and Astra Zeneca; travel grants from Abbott; leadership or fiduciary role in the working groups of the ESC Heart Failure Association on acute HF, advanced HF and cardio-renal metabolic diseases; associate editor for Heart Failure Reviews. AV reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Abbott Cardiovascular and Edwards Life sciences. LHL reports grants or contracts from the Swedish Heart\u2013Lung Foundation, the Swedish Research Council, the Stockholm County Council, the Erling Persson Foundation, the NHLBI and the EU Commission Horizon; consulting fees from Vifor Pharma, AstraZeneca, Pharmacosmos, Boehringer Ingelheim, BioPeutics, Edwards, Alleviant, Owkin; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Boehringer Ingelheim, AstraZeneca, Pharmacosmos, Novartis, Vifor Pharma, Bayer, Amgen, Novo Nordisk; leadership or fiduciary role at the ESC Heart Failure Association, the ESC, the HF Working Group of the Swedish Society of Cardiology. GF reports grants or contracts from the European Commission; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Bayer, Boehringer Ingelheim, Servier, and Novartis; participation on a Data Safety Monitoring Board or Advisory Board for Bayer; leadership or fiduciary role in the ESC Heart Failure Association, JACC Heart Failure and the European Journal of Heart Failure; other financial or non-financial interests from Medtronic, Bayer, Boehringer Ingelheim, Vifor, Amgen, Servier, Impulse Dynamics, Cardior, Novonordisc. JCF reports participation on a Data Safety Monitoring Board or Advisory Board for AstraZeneca (REALIZE-K DSMB), Windtree (SEISMIC DSMB), Sardocor (MUSIC DSMB), TikkunLev (SAB), NIH (Left v Left CEC), NIH (CONTEMP ICD DSMB), Abbott (BNP study CEC); leadership or fiduciary role in the HF Society of America.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}